A total of 319 Pasteurella multocida (Pm) strains isolated from pigs in Poland were examined. Phenotypic characterisation included: biochemical tests (to determine species, subspecies, and biovar), capsular typing, and antimicrobial susceptibility. Genotypic characterisation included detection of the toxA gene by PCR. All tested Pm strains were classified as Pm subsp. multocida: 87.2% biovar 3, 10.7%-2 and 0.9%-12. One strain was classified as biovar 1. Three strains of Pm did not suit any of the biovars. Using capsular typing methods, 77% of Pm strains isolated from nasal swabs belonged to type D and 33% to type A. Among Pm strains isolated from internal organs, 59.5% belonged to type A and 40.5% to type D. All the isolates showed a high susceptibility to β-lactams: ampicillin and amoxicilin with clavulonic acid (97.8%), penicillin (86.7%), doxicilline (100%), oxytetracycline (97.8%), and tetracycline (93.2%). It was found that all strains were susceptible to norfloxacin, 97.8% to enrofloxacin, and 95.6% to SxT. 24.4% and 15.6% of the strains were resistant to linco-spectin and tiamulin, respectively. The presence of toxA gene was confirmed by PCR in 20.8% of the strains isolated from nasal swabs and 29.1% of isolates from internal organs.
Pasteurella multocida (Pm) is a worldwide spread pathogen of mammals' and birds' respiratory tract. It was isolated from cats, dogs, cattle, horses, sheep, poultry, rodents, monkeys, rabbits, lions, panthers, lynx, buffalo, and humans (8, 11, 12) . Pasteurella multocida strains are also an important pathogen of swine. The strains with a high level of pathogenicity can be responsible for progressive atrophic rhinitis in pigs (18) .
Pasteurella multocida is a non-motile, Gramnegative, non-haemolytic coccoid bacterium. It grows well on the most enriched media. Pasteurella multocida strains do not produce spores, whereas many isolates produce capsule, which plays an important role in the pathogenicity of Pm.
The classification of the genus Pasteurella has changed over time. Mutters et al. (24) , divided Pasteurella genus into subsp. multocida, subsp. septica, and subsp. gallicida, based on DNA hybridisation results. Bisgaard et al. (3) determined the subspecies by their carbohydrate fermentation patterns. Based on the diversity to fermentation of different carbohydrates, Fegan et al. (13) described 10 biovars among Pm strains, and later Blackall et al. (4) added four other biovars to the classification system (37) .
On the basis of the differences in polysaccharide antigens of the Pm capsule, five capsular types were established (A, B, C, D, F).
The methods of serotyping of Pm also have changed over time. For capsular serotyping, Carter (6) used indirect haemagglutination test. Heddleston (22) used the gel diffusion precipitation test and distinguished 16 serotypes. Townsend et al. (36) developed PCR for capsular typing of Pm strains. To confirm capsular type of the strains, the guidelines provided by the OIE has recommended acriflavine and hyaluronidase tests (27) .
Progressive atrophic rhinitis caused by Pm and Bordetella bronchiseptica is an important disease from the economic point of view. A major pathogenicity factor of Pm strains is dermonecrotoxin (DNT) (1, 9) . Dermonecrotoxin, a 143-146 kDa heatsensitive protein, is encoded by toxA gene. Toxigenic strains can be distinguished in vitro by their toxigenicity for tissue culture, or in vivo by experimental infection of different species, including mice and guinea-pigs (10) . DNT of Pm strains can also be detected by ELISA and PCR.
Diversity among Pm strains suggests that classical bacteriological methods supported by molecular techniques are essential for the identification and characterisation of Pm strains.
The study has been focused on phenotypic and genotypic characterisation of Polish Pm strains isolated from pigs.
Material and Methods
Pasteurella multocida strains. A total of 319 Pm strains isolated from pigs were analysed. One hundred and seventy-eight Pm strains were isolated from nasal swabs and 141 strains were obtained from the lungs (115), heart (14) , kidneys (4), liver (4), lymph nodes (3), and spleen (1). Nasal swabs were obtained from 106 pigs' farms located in 13 Species were identified by testing nitrate reduction, urease activity, and glucose fermentation. Subspecies were defined on the basis of sorbitol fermentation. Biovars were determined by trehalose, galactose, xylose, arabinose, mannitol, lactose, sorbitol, maltose, and glucose fermentation and by testing the ODC activity.
Capsular serotyping. Capsular serotyping was performed according to Carter method. Type D strains were identified by their ability of agglutination in the presence of acriflavine solution. Type A strains were characterised by inhibition of capsular formation by hyaluronidase.
Antimicrobial susceptibility. Isolates of Pm were tested for their sensitivity to a panel of fifteen antibiotics by the disc diffusion method, following the recommendations and criteria provided by the National Committee for Clinical Laboratory Standards. It consists of ampicillin (10 μg/mL, Oxoid), amoxicillin with clavulonic acid (30 μg/mL, Oxoid), enrofloxacin (5 μg/mL, Oxoid), norfloxacin (10 μg/mL, Oxoid), doxicilline (30 μg/mL, Oxoid), ceftiofur (30 μg/mL, Oxoid), tetracycline (30 μg/mL, Oxoid), neomycin (30 μg/mL, Oxoid), oxytetracycline (30 μg/mL, Oxoid), gentamicine (10 μg/mL, Oxoid), penicillin (10 μg/mL, Oxoid), linco-spectin (109 μg/mL, Oxoid), SxT (1.25+23.75 μg/mL, BioMerieux), tiamulin (30 μg/mL, Rosco), and tylosin (30 μg/mL, Mast Group Ltd.).
Presence of DNT Pm. Primers, which amplify a 501bp fragment of the toxA gene of Pm, designed by Register et al. (31) were used. PCR was performed in 25 µl mixture containing 10xPCR Gold Buffer, 25 mM MgCl 2 solution, polymerase AmpliTaq Gold 5U/ml, 10 mM dNTPs (Fermentas), and 20 pM each of primer and water free from DNse and RNase. The reaction mixture was subjected to an amplification regimen consisting of an initial denaturation step (95°C, 10 min) followed by 40 cycles at 94°C (30 s), 56°C (30 s), and 72°C (30 s) and final elongation at 72°C (7 min), with the use of a T3-Biometra thermocycler.
Products obtained in PCR were separated by electrophoresis in 2% agarose gel with ethidium bromide in concentration of 1 μg/mL. The electrophoresis was done in 1xTAE buffer, at 350 mA. Into each well, 10 μl of reaction mixture and 2 μl of loading buffer 6xDNA Loading Dye (Fermentas) were inserted. The molecular weight of the obtained products was determined by comparison to the molecular weight of marker GeneRuler™ 100 bp DNA Ladder Plus (Fermentas). The agarose gels were photographed under UV light using EC3 Chemi HR 410 Imaging System (UK).
Results
Phenotypic characterisation. All Pm strains showed typical growth on agar plates; they were G (-) and were producing catalase. All isolates were oxidase positive, nitrate negative, lacked urease and haemolytic acivity, and all failed to grow on MacConkey agar. Additionally, the field isolates of Pm showed ornithine decarboxylase activity. Based on glucose, lactose, sorbitol, mannitol, trehalose, maltose, xylose, and arabinose fermentation all species were classified as Pm subsp. multocida. 87.2% of the species were classified as biovar 3, 10.7% as biovar 2, and 0.9% strains as biovar 12 (Pm subsp. multocida lactose positive). One strain was classified as biovar 1. Three strains could not be classified into any of the biovars. Table 1 shows the results of biovar classification based on the sugar fermentation.
Determination of capsule type. It was estimated that 77% of Pm isolates from nasal swabs belonged to capsule type D and 33% of the isolates belonged to type A. 59.5% of Pm strains isolated from internal organs belonged to type A and 40.5% to type D.
Antimicrobial susceptibility. All Pm isolates showed a high susceptibility to β-lactams: ampicillin and amoxicilin with clavulonic acid (97.8%), penicillin (86.7%); tetracyclines: doxicilline, oxytetracycline, and tetracycline (100%, 97.8%, and 93.2%, respectively). It was found that all strains were susceptible to norfloxacin, 97.8% to enrofloxacin, and 95.6% to SxT. 24.4% and 15.6% of the strains were resistant to lincospectin and tiamulin, respectively. Fig. 1 shows antimicrobial susceptibility results of Pm strains.
Molecular characterisation. Thirty-seven from 178 (20.8%) Pm isolates from nasal swabs were positive for the presence of toxA gene and produced the 501bp product by specific PCR. Fig. 2 shows gel-electrophoresis of PCR products obtained from DNA of Pm strains.
The toxA gene was detected in 28.7% of Pm isolates obtained from the lungs, 42.9% from heart, 25% from kidneys and liver. Pasteurella multocida isolates obtained from the lymph node and spleen were negative for toxA gene. (5) . He classified 103 from 107 tested Pm strains as Pm subsp. multocida and 69.9% of them belonged to biovar 3, whereas 14.5% to biovar 2. Similar results were also obtained in population of Hungarian Pm strains isolated from pigs. 67.7% Pm subsp. multocida belonged to biovar 3, 16.5% to biovar 2, and 7.9% to biovar 12 (35) . The study showed that 87.2% of tested Pm subsp. multocida strains belonged to biovar 3, 10.7% to biovar 2, and 0.9% to biovar 12.
To confirm the capsular type of Pm strains, acriflavine and hyaluronidase tests were used. It was demonstrated that Polish population of Pm strains from AR cases belonged mainly to type D (77%).
Lariviere et al. (20) reported that in Canada 53% Pm strains obtained from nasal swabs belonged to capsular type D and 47% to type A. The authors noted that capsular antigens of the tested strains did not correlate with clinical signs of AR. Pasteurella multocida strains isolated from nasal swabs in Japan were also represented mostly by capsule type D (68%) (33) . Similar results were shown by Lichtensteiner et al. (21) and Fussing et al. (14) . The percentage of Pm strains with D capsular type was 60% and 58.8%, respectively. The highest percentage (82.3%) of Pm strains with type D from AR case was demonstrated in Australia (15) .
Analysis of capsular type by multiplex PCR showed that type D was represented by 57.1%, 60%, 70.6% and 76% Pm strains in Czech Republic (16) , Hungary (37), England (7), and Germany (2), respectively.
Except determination of capsular type of Pm strains, it is important to define their ability to DNT production. Gardner et al. (15) (35) demonstrated that 93.1% of Chinese Pm strains isolated from swine were resistant to 3-10 antibiotics. Pm strains were resistant to gentamicine (13.7%), tetracicline (58%), and SxT (74.2%), while Polish isolates were sensitive to these antibiotics. Polish Pm strains were also multiresistant, 20% and 13.5% of them were resistant to 2 and 3 antibiotics, respectively. It was also demonstrated by Kuczkowski et al. (19) , who discovered that every fourteen Polish Pm strains isolated from geese or turkeys were resistant to at least six antibiotics.
Tang et al. (35) observed that multiresistance was more common in population of Pm with capsular type D. There is no correlation between the ability of Pm strains to DNT production and their multiresistance.
In summary, the study showed that all Pm strains isolated in Poland belonged to subsp. multocida and the majority of them represented biovar 3. The study also showed the difference in capsular type of Pm strains recovered from nasal swabs and from internal organs. The most strains from nasal swabs belonged to type D (77%), while the majority of strains from internal organs represented capsular type A (59.5%). ToxA gene was present in 20.8% of Pm strains from nasal swabs and in 29.1% of isolates from internal organs. All Pm isolates showed a high susceptibility to most tested antibiotics particularly to β-lactams and tetracyclines.
